4//SEC Filing
Celator Pharmaceuticals Inc 4
Accession 0000899243-16-024958
CIK 0001327467operating
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:24 PM ET
Size
16.2 KB
Accession
0000899243-16-024958
Insider Transaction Report
Form 4
Powell Fred M
V P & Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2016-07-12$27.46/sh−55,000$1,510,300→ 0 totalExercise: $2.79Exp: 2024-02-18→ Common Stock (55,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2016-07-06$27.13/sh−181,113$4,914,320→ 0 totalExercise: $3.12Exp: 2023-06-03→ Common Stock (181,113 underlying) - Disposition to Issuer
Common Stock
2016-07-12$30.25/sh−156,064$4,720,936→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2016-07-12$27.03/sh−50,000$1,351,500→ 0 totalExercise: $3.22Exp: 2024-02-18→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2016-07-12$28.93/sh−137,500$3,977,875→ 0 totalExercise: $1.32Exp: 2026-01-27→ Common Stock (137,500 underlying)
Footnotes (5)
- [F1]Disposed of pursuant to the merger under the Agreement and Plan of Merger dated as of May 27, 2016 among Jazz Pharmaceuticals Plc, Plex Merger Sub, Inc. and the Issuer (the "Merger") in exchange for a cash payment, representing the $30.25 purchase price per share of Issuer common stock in the Merger, multiplied by the number of shares.
- [F2]The option (initially exercisable for 253,000 shares, which had provided for vesting as follows: (i) 63,250 options vest on June 3, 2014; (ii) 173,943 options vest in eleven consecutive quarterly installments of 15,813 shares, each on the 3rd day of the respective month beginning September 3, 2014 and continuing through March 3, 2017 and (iii) 15,807 options vest on June 3, 2017) was canceled in the Merger in exchange for a cash payment, representing the difference between the exercise price per share of the option and $30.25, the purchase price per share of Issuer common stock in the Merger, multiplied by the number of shares.
- [F3]The option (which had provided for vesting as follows: (i) 12,500 options vest on February 18, 2015; and (ii) 37,500 options vest in 12 consecutive quarterly installments of 3,125 shares, each on the 18th day of the respective month beginning May 18, 2015 and continuing through February 18, 2018) was canceled in the Merger in exchange for a cash payment, representing the difference between the exercise price per share of the option and $30.25, the purchase price per share of Issuer common stock in the Merger, multiplied by the number of shares.
- [F4]The option (which had provided for vesting as follows: (i) 13,750 options vest on February 25, 2016; (ii) 37,818 options vest in 11 consecutive quarterly installments of 3,438 shares, each on the 25th day of the respective month beginning May 25, 2016 and continuing through November 25, 2018, and (iii) 3,432 options vest on February 25, 2019) was canceled in the Merger in exchange for a cash payment, representing the difference between the exercise price per share of the option and $30.25, the purchase price per share of Issuer common stock in the Merger, multiplied by the number of shares.
- [F5]The option (which had provided for vesting as follows: (i) 34,375 options vest on January 27, 2017; and (ii) 94,523 options vest in 11 consecutive quarterly installments of 8,593 shares vest on the 27th day of each respective month, beginning April 27, 2017 and continuing through October 27, 2019 and (iii) 8,602 options vest on January 27, 2020) was canceled in the Merger in exchange for a cash payment, representing the difference between the exercise price per share of the option and $30.25, the purchase price per share of Issuer common stock in the Merger, multiplied by the number of shares.
Documents
Issuer
Celator Pharmaceuticals Inc
CIK 0001327467
Entity typeoperating
Related Parties
1- filerCIK 0001327467
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 4:24 PM ET
- Size
- 16.2 KB